R&D Consult ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  8.7% 6.9% 9.3% 9.6% 10.8%  
Credit score (0-100)  28 33 26 24 23  
Credit rating  BB BBB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  1,326 1,564 1,537 1,514 1,564  
EBITDA  224 48.0 142 133 128  
EBIT  224 48.0 142 133 128  
Pre-tax profit (PTP)  224.0 44.0 139.0 135.0 129.7  
Net earnings  175.0 33.0 108.0 105.0 100.9  
Pre-tax profit without non-rec. items  224 44.0 139 135 130  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  464 427 421 409 387  
Interest-bearing liabilities  4.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  880 727 652 640 524  

Net Debt  -597 -464 -269 -272 -351  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,326 1,564 1,537 1,514 1,564  
Gross profit growth  28.1% 17.9% -1.7% -1.5% 3.3%  
Employees  2 2 2 2 2  
Employee growth %  100.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  880 727 652 640 524  
Balance sheet change%  48.6% -17.4% -10.3% -1.8% -18.1%  
Added value  224.0 48.0 142.0 133.0 128.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  16.9% 3.1% 9.2% 8.8% 8.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  30.4% 6.0% 20.6% 20.9% 22.3%  
ROI %  55.5% 10.7% 33.5% 32.5% 32.7%  
ROE %  43.6% 7.4% 25.5% 25.3% 25.4%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  52.7% 58.7% 64.6% 63.9% 73.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -266.5% -966.7% -189.4% -204.5% -273.4%  
Gearing %  0.9% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 200.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  2.1 2.4 2.8 2.8 3.8  
Current Ratio  2.1 2.4 2.8 2.8 3.8  
Cash and cash equivalent  601.0 464.0 269.0 272.0 350.6  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  464.0 427.0 421.0 409.0 387.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  112 24 71 67 64  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  112 24 71 67 64  
EBIT / employee  112 24 71 67 64  
Net earnings / employee  88 17 54 53 50